ucsf logo

PSPG/CERSI Seminar Series 2015-2016

DateSpeakerTitleHost
09/27/16

Richard Lalonde, Pharm.D.

Pfizer

Quantitative Clinical Pharmacology and Drug Development StrategyNatalia Khuri
10/11/16

Margaret Porter Scott, Ph.D.

Genentech

 Ken Hallenbeck
10/25/16

Gai Ayalon, Ph.D.

Genentech

Untangling Tau: Targeting tau with antibodies for Alzheimer's diseaseNadav Ahituv
11/8/16

Adrian Ray, Ph.D.

Gilead

Clinical relevance and complexity of renal transport pathwaysLes Benet
01/10/17

Lara Mangravite, Ph.D.

Sage Biosciences

Open ecosystems for systems biology applications in pharmaceutical scienceDeanna Kroetz
01/24/17

Kelly Dooley, Ph.D.

Johns Hopkins University School of Medicine

 Rada Savic
02/14/17

Alex Sparreboom, Ph.D.

Ohio State University

Kinase-mediated regulation of ADME associated proteinsDeanna Kroetz
02/28/17

Marc Caron, Ph.D.

Duke University

Physiological and Therapeutic Implications of GPCR Functional SelectivityBrian Shoichet
03/14/17

Peter Senter, Ph.D.

Seattle Genetics

 Frank Szoka
04/11/17

Steven Kern, Ph.D.

Gates Foundation

Bringing Innovation in Drug Development Science to Global Health:  is this possible when target cost are $1 ?Natalia Khuri
05/09/17

Frank Weichold, Ph.D.

FDA

Trends in Regulatory ScienceRui Zhang
05/23/17

Paula Hammond, Ph.D.

MIT

 Tejal Desai